MedTrace Logo

An Open Label Study of Chronic Polyethyleneglycol3350 Use in Constipated Patients

NCT00164125 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 300

Last updated 2013-02-07

No results posted yet for this study

Summary

To evaluate the safety of extended use of polyethyleneglycol3350 laxative in constipated patients.

Conditions

Interventions

DRUG

polyethyleneglycol3350

Sponsors & Collaborators

  • Braintree Laboratories

    lead INDUSTRY

Principal Investigators

  • Jorge Herrera, MD · University of South Alabama

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Primary Completion
2004-11-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00164125 on ClinicalTrials.gov